---
title: "Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286757134.md"
description: "Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News"
datetime: "2026-05-18T02:45:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286757134.md)
  - [en](https://longbridge.com/en/news/286757134.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286757134.md)
---

# Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News

Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News

### Related Stocks

- [CNTX.US](https://longbridge.com/en/quote/CNTX.US.md)
- [BCAB.US](https://longbridge.com/en/quote/BCAB.US.md)

## Related News & Research

- [Context Therapeutics Pays $6.5 Million to Make BioAtla Antibody Licenses Perpetual and Royalty-Free](https://longbridge.com/en/news/286758291.md)
- [Context Therapeutics Decline Means Insider Profits Down To US$237k](https://longbridge.com/en/news/286911340.md)
- [ChiroTouch Launches CT Pay, Putting Up to $100 a Day Back in Chiropractors' Pockets](https://longbridge.com/en/news/286810158.md)
- [Heartflow Q1 revenue rises 41% and lifts 2026 outlook](https://longbridge.com/en/news/286460622.md)
- [CTF Life Launches Hong Kong's First Indexed Universal Life Insurance Plan Linked to BNP Paribas' Indices](https://longbridge.com/en/news/287040545.md)